{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:57Z","timestamp":1792787937442,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special","doi-asserted-by":"publisher","award":["201614035"],"award-info":[{"award-number":["201614035"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Major Collaborative Innovation Project","award":["2016-I2M-1-011"],"award-info":[{"award-number":["2016-I2M-1-011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0909-z","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T15:53:32Z","timestamp":1542988412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers"],"prefix":"10.1186","volume":"17","author":[{"given":"Na-Qiong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Lin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Gang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Xia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,23]]},"reference":[{"issue":"25 Suppl 2","key":"909_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Circulation. 2014;129(25 Suppl 2):S1\u2013S45.","journal-title":"Circulation"},{"key":"909_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa1300955","volume":"371","author":"MJ Landray","year":"2014","unstructured":"HPS2-THRIVE Collaborative Group, Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, et al. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med. 2014;371:203\u201312.","journal-title":"N Engl J Med"},{"key":"909_CR3","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC\/EAS guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37:2999\u20133058.","journal-title":"Eur Heart J"},{"key":"909_CR4","first-page":"937","volume":"31","author":"Joint Committee on guidelines for the prevention and control of dyslipidemia in Chinese adults","year":"2016","unstructured":"Joint Committee on guidelines for the prevention and control of dyslipidemia in Chinese adults. Chinese adult dyslipidemia guideline (2016 revision edition). Chin Cir J. 2016;31:937\u201353.","journal-title":"Chin Cir J"},{"key":"909_CR5","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372:2387\u201397.","journal-title":"N Engl J Med"},{"key":"909_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/1755-5922.12072","volume":"32","author":"A Kei","year":"2014","unstructured":"Kei A, Tellis C, Liberopoulos E, Tselepis A, Elisaf M. Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid\/laropiprant on oxidative stress markers in patients with mixed dyslipidemia. Cardiovasc Ther. 2014;32:139\u201346.","journal-title":"Cardiovasc Ther"},{"key":"909_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1517\/14656566.2016.1118055","volume":"17","author":"MC Serban","year":"2016","unstructured":"Serban MC, Banach M, Mikhailidis DP. Clinical implications of the IMPROVE-IT trial in the light of current and future lipid-lowering treatment options. Expert Opin Pharmacother. 2016;17:369\u201380.","journal-title":"Expert Opin Pharmacother"},{"key":"909_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/07853890.2016.1168935","volume":"48","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Li S, Guo YL, Wu NQ, Zhu CG, Gao Y, et al. Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: evidence from a large cohort of Chinese patients undergoing coronary angiography. Ann Med. 2016;48:305\u201312.","journal-title":"Ann Med"},{"key":"909_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1161\/ATVBAHA.116.308388","volume":"37","author":"S Takase","year":"2017","unstructured":"Takase S, Matoba T, Nakashiro S, Mukai Y, Inoue S, Oi K, et al. Ezetimibe in combination with statins ameliorates endothelial dysfunction in coronary arteries after stenting: the CuVIC trial (effect of cholesterol absorption inhibitor usage on target vessel dysfunction after coronary stenting), a Multicenter Randomized Controlled Trial. Arterioscler Thromb Vasc Biol. 2017;37:350\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"909_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jacl.2015.07.013","volume":"9","author":"K Homma","year":"2015","unstructured":"Homma K, Homma Y, Ozawa H, Shiina Y, Shibata T, Yoshida T, et al. Comparison of the effects of low-dose rosuvastatin on plasma levels of cholesterol and oxidized low-density lipoprotein in 3 ultracentrifugally separated low-density lipoprotein subfractions. J Clin Lipidol. 2015;9:751\u20137.","journal-title":"J Clin Lipidol"},{"key":"909_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jjcc.2015.05.017","volume":"67","author":"T Nishikido","year":"2016","unstructured":"Nishikido T, Oyama J, Keida T, Ohira H, Node K. High-dose statin therapy with rosuvastatin reduces small dense LDL and MDA-LDL: the standard versus high-dose therApy with Rosuvastatin for lipiD lowering (SARD) trial. J Cardiol. 2016;67:340\u20136.","journal-title":"J Cardiol"},{"key":"909_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","volume":"380","author":"B Mihaylova","year":"2012","unstructured":"Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581\u201390.","journal-title":"Lancet"},{"key":"909_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jacl.2014.04.002","volume":"8","author":"XL Li","year":"2014","unstructured":"Li XL, Li JJ, Guo YL, Zhu CG, Xu RX, Li S, et al. Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention. J Clin Lipidol. 2014;8:423\u201332.","journal-title":"J Clin Lipidol"},{"key":"909_CR14","doi-asserted-by":"crossref","first-page":"e001412","DOI":"10.1161\/JAHA.114.001412","volume":"4","author":"XL Li","year":"2015","unstructured":"Li XL, Guo YL, Zhu CG, Xu RX, Qing P, Wu NQ, et al. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg\/dL. J Am Heart Assoc. 2015;4:e001412.","journal-title":"J Am Heart Assoc"},{"key":"909_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1476-511X-12-137","volume":"12","author":"K Torimoto","year":"2013","unstructured":"Torimoto K, Okada Y, Mori H, Hajime M, Tanaka K, Kurozumi A, et al. Efficacy of combination of ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes. Lipids Health Dis. 2013;12:137.","journal-title":"Lipids Health Dis"},{"key":"909_CR16","doi-asserted-by":"publisher","first-page":"R16","DOI":"10.1186\/cc13695","volume":"18","author":"NW Tsai","year":"2014","unstructured":"Tsai NW, Lee LH, Huang CR, Chang WN, Chang YT, Su YJ, et al. Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome. Crit Care. 2014;18:R16.","journal-title":"Crit Care"},{"key":"909_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2013.08.013","volume":"231","author":"E Moutzouri","year":"2013","unstructured":"Moutzouri E, Liberopoulos EN, Tellis CC, Milionis HJ, Tselepis AD, Elisaf MS. Comparison of the effect of simvastatin versus simvastatin\/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia. Atherosclerosis. 2013;231:8\u201314.","journal-title":"Atherosclerosis"},{"key":"909_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/clc.21017","volume":"35","author":"B Huang","year":"2012","unstructured":"Huang B, Cheng Y, Xie Q, Lin G, Wu Y, Feng Y, et al. Effect of 40 mg versus 10 mg of atorvastatin on oxidized low-density lipoprotein, high-sensitivity C-reactive protein, circulating endothelial-derived microparticles, and endothelial progenitor cells in patients with ischemic cardiomyopathy. Clin Cardiol. 2012;35:125\u201330.","journal-title":"Clin Cardiol"},{"key":"909_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ijcard.2011.01.062","volume":"158","author":"AE Pesaro","year":"2012","unstructured":"Pesaro AE, Serrano CV Jr, Fernandes JL, Cavalcanti AB, Campos AH, Martins HS, et al. Pleiotropic effects of ezetimibe\/simvastatin vs. high dose simvastatin. Int J Cardiol. 2012;158:400\u20134.","journal-title":"Int J Cardiol"},{"key":"909_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.atherosclerosis.2015.02.003","volume":"239","author":"MU Aydin","year":"2015","unstructured":"Aydin MU, Aygul N, Altunkeser BB, Unlu A, Taner A. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction. Atherosclerosis. 2015;239:439\u201343.","journal-title":"Atherosclerosis"},{"key":"909_CR21","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.5551\/jat.4077","volume":"17","author":"Y Homma","year":"2010","unstructured":"Homma Y, Michishita I, Hayashi H, Shigematsu H. Kanagawa lipid research group. Effects of low-dose simvastatin on the distribution of plasma cholesterol and oxidized low-density lipoprotein in three ultra-centrifugally separated low-density lipoprotein subfractions: 12-month, open-label trial. J Atheroscler Thromb. 2010;17:1049\u201353.","journal-title":"J Atheroscler Thromb"},{"key":"909_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jacc.2015.11.037","volume":"67","author":"PM Ridker","year":"2016","unstructured":"Ridker PM. A Test in Context: High-sensitivity C-reactive protein. J Am Coll Cardiol. 2016;67:712\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"909_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","volume":"118","author":"PM Ridker","year":"2016","unstructured":"Ridker PM. From C-reactive protein to Interleukin-6 to Interleukin-1: moving upstream to identify novel targets for Atheroprotection. Circ Res. 2016;118:145\u201356.","journal-title":"Circ Res"},{"key":"909_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/1755-5922.12057","volume":"32","author":"R Krysiak","year":"2014","unstructured":"Krysiak R, Zmuda W, Okopien B. The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia. Cardiovasc Ther. 2014;32:40\u20136.","journal-title":"Cardiovasc Ther"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0909-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0909-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0909-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T16:44:32Z","timestamp":1662482672000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0909-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["909"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0909-z","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,23]]},"assertion":[{"value":"28 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our study complied with the Declaration of Helsinki and was approved by the hospital\u2019s ethical review board (Fu Wai Hospital & National Center for Cardiovascular Diseases, Beijing, China). Informed written consents were obtained from all the participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participants"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"265"}}